Showing results (361-370 of 529) with videos related to
Sort By:
Pageof 53
Schizophrenia (Heidelberg, Germany)|March 16, 2024
Mapping the landscape: a bibliometric analysis of resting-state fMRI research on schizophrenia over the past 25 yearsLinhan Fu, Remilai Aximu, Guoshu Zhao, et al.Schizophrenia (Heidelberg, Germany)|April 11, 2024
Variations to plasma H2O2 levels and TAC in chronical medicated and treatment-resistant male schizophrenia patients: Correlations with psychopathologyHaidong Yang, Wenxi Sun, Man Yang, et al.Schizophrenia (Heidelberg, Germany)|April 6, 2024
The Ethiopian Cognitive Assessment battery in Schizophrenia (ECAS): a validation studyYohannes Gebreegziabhere, Kassahun Habatmu, Matteo Cella, et al.Schizophrenia (Heidelberg, Germany)|January 27, 2024
Cerebro-cerebellar gray matter abnormalities associated with cognitive impairment in patients with recent-onset and chronic schizophreniaNaok Kang, Subin Chung, Sang-Hyuk Lee, et al.Schizophrenia (Heidelberg, Germany)|February 3, 2024
The neutrophil-to-Lymphocyte ratio is associated with clinical symptoms in first-episode medication-naïve patients with schizophreniaXuan Wang, Xiaofang Chen, Xiaoni Guan, et al.Schizophrenia (Heidelberg, Germany)|August 31, 2024
Structural and functional connectivity in relation to executive functions in antipsychotic-naïve patients with first episode schizophrenia and levels of glutamatergic metabolitesTina D Kristensen, Karen S Ambrosen, Jayachandra M Raghava, et al.Schizophrenia (Heidelberg, Germany)|September 30, 2024
Irregularity of visual motion perception and negative symptoms in schizophreniaYi Fan, Yunhai Tao, Jue Wang, et al.Schizophrenia (Heidelberg, Germany)|September 30, 2024
Exploring the molecular targets of fingolimod and siponimod for treating the impaired cognition of schizophrenia using network pharmacology and molecular dockingChao Li, Chuanjun Zhuo, Xiaoyan Ma, et al.Schizophrenia (Heidelberg, Germany)|October 9, 2024
Psychotic symptoms associated increased CpG methylation of metabotropic glutamate receptor 8 gene in Chinese Han males with schizophrenia and methamphetamine induced psychotic disorder: a longitudinal studyHuixi Dong, Tao Luo, Cheng Yang, et al.Schizophrenia (Heidelberg, Germany)|August 22, 2024
Prevalence and incidence measures for schizophrenia among commercial health insurance and medicaid enrolleesMolly T Finnerty, Atif Khan, Kai You, et al.Pageof 53